The HIV-1 leader RNA conformational switch regulates RNA dimerization but does not regulate mRNA translation

Biochemistry

Volumn 44, Issue 25, 2005, Pages 9058-9066

  Abbink, Truus E M ^a   Ooms, Marcel ^a   Haasnoot, P C Joost ^a   Berkhout, Ben ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CONFORMATIONS; DIMERIZATION; DIMERS; GENES; IMMUNOLOGY; MUTAGENESIS;

DIMER INITIATION SITES (DIS); IMMUNODEFICIENCY; LONG DISTANCE INTERACTIONS (LDI); SPLICE DONORS (SD);

RNA;

SIGNAL PEPTIDE;

ARTICLE; CONTROLLED STUDY; DIMERIZATION; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; RNA CONFORMATION; RNA SEQUENCE; RNA STRUCTURE; RNA TRANSLATION; START CODON; TRANSLATION INITIATION; TRANSLATION REGULATION;

BASE SEQUENCE; DIMERIZATION; HIV-1; MOLECULAR SEQUENCE DATA; MUTATION; NUCLEIC ACID CONFORMATION; PROTEIN BIOSYNTHESIS; RNA, MESSENGER; RNA, VIRAL; THERMODYNAMICS; TRANSCRIPTION, GENETIC;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 21744452846     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi0502588     Document Type: Article

References (56)

1. Olsthoorn, R. C. L., Mertens, S., Brederode, F. T., and Bol, J. F. (1999) A conformational switch at the 3′ end of a plant virus RNA regulates viral replication, EMBO J. 18, 4856-4864.
2. Nudler, E., and Mironov, A. S. (2004) The riboswitch control of bacterial metabolism, Trends Biochem. Sci. 29, 11-17.
3. Lazinski, D. W., and Taylor, J. M. (1995) Regulation of the hepatitis delta virus ribozymes: To cleave or not to cleave? RNA 1, 225-233.
4. Mandal, M., and Breaker, R. R. (2004) Gene regulation by riboswitches, Nat. Rev. Mol. Cell Biol. 5, 451-463.
5. Ooms, M., Huthoff, H., Russell, R., Liang, C., and Berkhout, B. (2004) A riboswitch regulates RNA dimerization and packaging in human immunodeficiency virus type 1 virions, J. Virol. 78, 10814-10819.
6. Abbink, T. E. M., and Berkhout, B. (2003) A novel long distance base-pairing interaction in human immunodeficiency virus type 1 RNA occludes the gag start codon, J. Biol. Chem. 278, 11601-11611.
7. Huthoff, H., and Berkhout, B. (2001) Two alternating structures for the HIV-1 leader RNA, RNA 7, 143-157.
8. D'Souza, V., and Summers, M. F. (2004) Structural basis for packaging the dimeric genome of Moloney murine leukaemia virus, Nature 431, 586-590.
9. Puglisi, J. D., Tan, R., Calnan, B. J., Frankel, A. D., and Williamson, J. R. (1992) Conformation of the TAR RNA-arginine complex by NMR spectroscopy, Science 257, 76-80.
10. Aboul-ela, F., Karn, J., and Varani, G. (1995) The structure of the human immunodeficiency virus type 1 TAR RNA reveals principles of RNA recognition by Tat protein. J. Mol. Biol. 253, 313-332.
11. Aboul-ela, F., Karn, J., and Varani, G. (1996) Structure of HIV-1 TAR RNA in the absence of ligands reveals a novel conformation of the trinucleotide bulge, Nucleic Acids Res. 24, 3974-3981.
12. Ippolito, J. A., and Steitz, T. A. (1998) A 1.3-Å resolution crystal structure of the HIV-1 trans-activation response region RNA stem reveals a metal ion-dependent bulge conformation, Proc. Natl. Acad. Sci. U.S.A. 95, 9819-9824.
13. Berkhout, B. (1992) Structural features in TAR RNA of human and simian immunodeficiency viruses: A phylogenetic analysis, Nucleic Acids Res. 20, 27-31.
14. Klaver, B., and Berkhout, B. (1994) Evolution of a disrupted TAR RNA hairpin structure in the HIV-1 virus, EMBO J. 13, 2650-2659.
15. Dingwall, C., Ernberg, I., Gait, M. J., Green, S. M., Heaphy, S., Karn, J., Lowe, A. D., Singh, M., Skinner, M. A., and Valerio, R. (1989) Human immunodeficiency virus 1 tat protein binds trans-activating-responsive region (TAR) RNA in vitro. Proc. Natl. Acad. Sci. U.S.A. 86, 6925-6929.
16. Wei, P., Garber, M. E., Fang, S.-M., Fisher, W. H., and Jones, K. A. (1998) A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA, Cell 92, 451-462.
17. Berkhout, B., Silverman, R. H., and Jeang, K. T. (1989) Tat transactivates the human immunodeficiency virus through a nascent RNA target, Cell 59, 273-282.
18. Klasens, B. I. F., Das, A. T., and Berkhout, B. (1998) Inhibition of polyadenylation by stable RNA secondary structure. Nucleic Acids Res. 26, 1870-1876.
19. Klasens, B. I. F., Thiesen, M., Virtanen, A., and Berkhout, B. (1999) The ability of the HIV-1 AAUAAA signal to bind polyadenylation factors is controlled by local RNA structure, Nucleic Acids Res. 27, 446-454.
20. Beerens, N., Groot, F., and Berkhout, B. (2001) Initiation of HIV-1 reverse transcription is regulated by a primer activation signal, J. Biol. Chem. 276, 31247-31256.
21. Beerens, N., and Berkhout, B. (2002) The tRNA primer activation signal in the HIV-1 genome is important for initiation and processive elongation of reverse transcription, J. Virol. 76, 2329-2339.
22. Laughrea, M., and Jette, L. (1994) A 19-nucleotide sequence upstream of the 5′ major splice donor is part of the dimerization domain of human immunodeficiency virus 1 genomic RNA, Biochemistry 33, 13464-13474.
23. Lever, A., Gottlinger, H., Haseltine, W., and Sodroski, J. (1989) Identification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virions, J. Virol. 63, 4085-4087.
24. Aldovini, A., and Young, R. A. (1990) Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging results in production of noninfectious virus, J. Virol. 64, 1920-1926.
25. Harrison, G. P., and Lever, A. M. L. (1992) The human immunodeficiency virus type 1 packaging signal and major splice donor region have a conserved stable secondary structure, J. Virol. 66, 4144-4153.
26. Baudin, F., Marquet, R., Isel, C., Darlix, J. L., Ehresmann, B., and Ehresmann, C. (1993) Functional sites in the 5′ region of human immunodeficiency virus type 1 RNA form defined structural domains, J. Mol. Biol. 229, 382-397.
27. Clavel, F., and Orenstein, J. M. (1990) A mutant of human immunodeficiency virus with reduced RNA packaging and abnormal particle morphology, J. Virol. 64, 5230-5234.
28. Purcell, D. F. J., and Martin, M. A. (1993) Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity, J. Virol. 67, 6365-6378.
29. O'Reilly, M. M., McNally, M. T., and Beemon, K. L. (1995) Two strong 5′ splice sites and competing, suboptimal 3′ splice sites involved in alternative splicing of human immunodeficiency virus type 1 RNA, Virology 213, 373-385.
30. Kerwood, D. J., Cavaluzzi, M. J., and Borer, P. N. (2001) Structure of SL4 RNA from the HIV-1 packaging signal, Biochemistry 40, 14518-14529.
31. Skripkin, E., Paillait, J. C., Marquet, R., Ehresmann, B., and Ehresmann, C. (1994) Identification of the primary site of the human immunodeficiency virus type 1 RNA dimerization in vitro, Proc. Natl. Acad. Sci. U.S.A. 91, 4945-4949.
32. Paillart, J. C., Marquet, R., Skripkin, E., Ehresmann, B., and Ehresmann, C. (1994) Mutational analysis of the bipartite dimer linkage structure of human immunodeficiency virus type 1 genomic RNA, J. Biol. Chem. 269, 27486-27493.
33. Muriaux, D., Girard, P.-M., Bonnet-Mathoniere, B., and Paoletti, J. (1995) Dimerization of HIV-1 LAI RNA at low ionic strength, J. Biol. Chem. 270, 8209-8216.
34. Clever, J. L., Wong, M. L., and Parslow, T. G. (1996) Requirements for kissing-loop-mediated dimerization of human immunodeficiency virus RNA, J. Virol. 70, 5902-5903.
35. Haddrick, M., Lear, A. L., Cann, A. J., and Heaphy, S. (1996) Evidence that a kissing loop structure facilitates genomic RNA dimerisation in HIV-1, J. Mol. Biol. 259, 58-68.
36. Laughrea, M., and Jette, L. (1996) Kissing-loop model of HIV-1 genome dimerization: HIV-1 RNAs can assume alternative dimeric forms, and all sequences upstream or downstream of hairpin 248-271 are dispensable for dimer formation, Biochemistry 35, 1589-1598.
37. Laughrea, M., and Jette, L. (1996) HIV-1 genome dimerization: Formation kinetics and thermal stability of dimeric HIV-1LAI RNAs are not improved by the 1-232 and 296-790 regions flanking the kissing-loop domain, Biochemistry 35, 9366-9374.
38. Muriaux, D., Fosse, P., and Paoletti, J. (1996) A kissing complex together with a stable dimer is involved in the HIV-1 LAI RNA dimerization process in vitro, Biochemistry 35, 5075-5082.
39. Clever, J. L., Mirandar, D., Jr., and Parslow, T. G. (2002) RNA structure and packaging signals in the 5′ leader region of the human immunodeficiency virus type 1 genome, J. Virol. 76, 12381-12387.
40. Helga-Maria, C., Hammarskjold, M. L., and Rekosh, D. (1999) An intact TAR element and cytoplasmic localization are necessary for efficient packaging of human immunodeficiency virus type 1 genomic RNA, J. Virol. 73, 4127-4135.
41. Russell, R. S., Hu, J., Beriault, V., Mouland, A. J., Laughrea, M., Kleiman, L., Wainberg, M. A., and Liang, C. (2003) Sequences downstream of the 5′ splice donor site are required for both packaging and dimerization of human immunodeficiency virus type 1 RNA, J. Virol. 77, 84-96.
42. Klaver, B., and Berkhout, B. (1994) Comparison of 5′ and 3′ long terminal repeat promoter function in human immunodeficiency virus, J. Virol. 68, 3830-3840.
43. Berkhout, B., van Wamel, J., and Klaver, B. (1995) Requirements for DNA strand transfer during reverse transcription in mutant HIV-1 virions, J. Mol. Biol. 252, 59-69.
44. Beerens, N., Klaver, B., and Berkhout, B. (2000) A structured RNA motif is involved in the correct placement of the tRNALys3 primer onto the human immunodeficiency virus genome, J. Virol. 74, 2227-2238.
45. Verhoef, K., Koper, M., and Berkhout, B. (1997) Determination of the minimal amount of Tat activity required for human immunodeficiency virus type 1 replication, Virology 237, 228-236.
46. Kotsopoulou, E., Kim, V. N., Kingsman, A. J., Kingsman, S. M., and Mitrophanous, K. A. (2000) A Rev-independent human immunodeficiency virus type 1 (HIV-1)-based vector that exploits a codon-optimized HIV-1 gag-pol gene, J. Virol. 74, 4839-4852.
47. Mathews, D. H., Sabina, J., Zuker, M., and Turner, D. H. (1999) Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure, J. Mol. Biol. 288, 911-940.
48. Zuker, M., and Turner, D. H. (1999) Algorithms and thermodynamics for RNA secondary structure prediction: A practical guide, in RNA biochemistry and biotechnology (Barciszewski, J., and Clark, B. F. C., Eds.) pp 11-43, Kluwer Academic Publishers, Dordrecht, The Netherlands.
49. Das, A. T., Klaver, B., Klasens, B. I. F., van Wamel, J. L. B., and Berkhout, B. (1997) A conserved hairpin motif in the R-U5 region of the human immunodeficiency virus type 1 RNA genome is essential for replication, J. Virol. 71, 2346-2356.
50. Butsch, M., and Boris-Lawrie, K. (2002) Destiny of unspliced retroviral RNA: Ribosome and/or virion? J. Virol. 76, 3089-3094.
51. Liang, C., Hu, J., Russell, R. S., and Wainberg, M. A. (2002) Translation of Pr55(gag) Augments Packaging of Human Immunodeficiency Virus Type 1 RNA in a Cis-Acting Manner, AIDS Res. Hum. Retroviruses 18, 1117-1126.
52. Poon, D. T., Chertova, E. N., and Ott, D. E. (2002) Human immunodeficiency virus type 1 preferentially encapsidates genomic RNAs that encode Pr55(Gag): Functional linkage between translation and RNA packaging, Virology 293, 368-378.
53. Dorman, N., and Lever, A. (2000) Comparison of viral genomic RNA sorting mechanisms in human immunodeficiency virus type 1 (HIV-1), HIV-2, and moloney murine leukemia virus, J. Virol. 74, 11413-11417.
54. Goh, W. C., Rogel, M. E., Kinsey, C. M., Michael, S. F., Fultz, P. N., Nowak, M. A., Hahn, B. H., and Emerman, M. (1998) HIV-1 Vpr increases viral expression by manipulation of the cell cycle: A mechanism for selection of Vpr in vivo, Nat. Med. 4. 65-71.
55. Gummuluru, S., and Emerman, M. (1999) Cell cycle- and Vpr-mediated regulation of human immunodeficiency virus type 1 expression in primary and transformed T-cell lines, J. Virol. 73, 5422-5430.
56. Paillart, J. C., Dettenhofer, M., Yu, X. F., Ehresmann, C., Ehresmann, B., and Marquet, R. (2004) First snapshots of the HIV-1 RNA structure in infected cells and in virions, J. Biol. Chem. 279, 48397-48403.